Effect of disease-specific complications on the prediction of utilities in Parkinson's disease

被引：0
|
作者：
Siebert, U
Bornschein, B
Spottke, EA
Dodel, R
机构：
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA
[2] Univ Munich, Munich, Germany
[3] Univ Bonn, D-5300 Bonn, Germany
来源：
VALUE IN HEALTH | 2004年 / 7卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)66128-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：794 / 794
页数：1
相关论文
共 50 条
  • [21] The disease-specific proteins in striatum of the mouse models of Parkinson's disease induced by rotenone and MPTP
    Zhou, Changqing
    Li, Shanshan
    Wang, Min
    Chen, Zhongmei
    Peng, Guoguang
    SCIENCEASIA, 2020, 46 (02): : 142 - 150
  • [22] Modeling depression in Parkinson disease Disease-specific and nonspecific risk factors
    Leentjens, Albert F. G.
    Moonen, Anja J. H.
    Dujardin, Kathy
    Marsh, Laura
    Martinez-Martin, Pablo
    Richard, Irene H.
    Starkstein, Sergio E.
    Kohler, Sebastian
    NEUROLOGY, 2013, 81 (12) : 1036 - 1043
  • [23] Detection of a Parkinson's Disease-Specific MicroRNA Signature in Nasal and Oral Swabs
    Schliesser, Patricia
    Struebing, Felix L.
    Northoff, Bernd H.
    Kurz, Anna
    Remi, Jan
    Holdt, Lesca
    Hoeglinger, Guenter U.
    Herms, Jochen
    Koeglsperger, Thomas
    MOVEMENT DISORDERS, 2023, 38 (09) : 1706 - 1715
  • [24] Impact of a Parkinson's Disease-Specific Order Set on Inpatient Medication Administration
    Larson, D.
    Zadikoff, C.
    Afshari, M.
    Kianirad, Y.
    MOVEMENT DISORDERS, 2018, 33 : S508 - S509
  • [25] PERCEIVED RELEVANCE OF GENERIC AND DISEASE-SPECIFIC PATIENT-REPORTED OUTCOME MEASURES IN PARKINSON'S DISEASE
    Reimer, Jan
    Hagell, Peter
    QUALITY OF LIFE RESEARCH, 2004, 13 (09) : 1602 - 1602
  • [26] Generation of disease-specific induced pluripotent stem cells from sporadic Parkinson's disease patients
    Kondo, Takayuki
    Inoue, Haruhisa
    Minakawa, Eiko
    Koshiba, Yasushi
    Washida, Kazuo
    Egawa, Naohiro
    Takahashi, Kazutoshi
    Nakahata, Tatsutoshi
    Yamanaka, Shinya
    Takahashi, Ryosuke
    NEUROSCIENCE RESEARCH, 2011, 71 : E191 - E191
  • [27] A high-throughput disease-specific phenotype detection system of Parkinson's disease for drug screening
    Isihkawa, K. I.
    Akihiro, Y.
    Okano, H.
    Hattori, N.
    Akamatsu, W.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 353 - 353
  • [28] Proteomic analysis of tear-fluid reveals disease-specific patterns in patients with Parkinson's Disease
    Boerger, M.
    Funke, S.
    Maass, F.
    Leha, A.
    Roser, A. E.
    Wuestemann, A. K.
    Baehr, M.
    Grus, F.
    Lingor, P.
    MOVEMENT DISORDERS, 2018, 33 : S736 - S736
  • [29] Measuring disease-specific utilities for chronic obstructive pulmonary disease health- and exacerbation profiles
    Rutten-van Molken, M.
    Hoogendoorn-Lips, M.
    Lamers, L.
    VALUE IN HEALTH, 2006, 9 (06) : A265 - A266
  • [30] Disease-specific properties of the Hamilton Rating Scale for Depression in patients with stroke, Alzheimer's dementia, and Parkinson's disease
    Naarding, P
    Leentjens, AFG
    van Kooten, F
    Verhey, FRJ
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2002, 14 (03) : 329 - 334
12345